KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,277,000 | +20.6% | 67,270 | -20.0% | 0.13% | -56.6% |
| Q3 2020 | $1,059,000 | -48.0% | 84,087 | -50.0% | 0.30% | -55.0% |
| Q2 2020 | $2,035,000 | +58.1% | 168,174 | 0.0% | 0.66% | -11.6% |
| Q1 2020 | $1,287,000 | -39.0% | 168,174 | +41.9% | 0.74% | -26.7% |
| Q4 2019 | $2,110,000 | +53.5% | 118,500 | 0.0% | 1.01% | +8.0% |
| Q3 2019 | $1,375,000 | -47.6% | 118,500 | 0.0% | 0.94% | -46.0% |
| Q2 2019 | $2,625,000 | -22.6% | 118,500 | 0.0% | 1.73% | -34.9% |
| Q1 2019 | $3,391,000 | +14.4% | 118,500 | -21.0% | 2.66% | -6.3% |
| Q4 2018 | $2,963,000 | – | 150,000 | – | 2.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |